胸廓出口减压联合开放与腔内中心静脉重建治疗高度症状性患者
本研究回顾性分析53例高度症状性胸廓出口综合征或同侧透析通路相关中心静脉梗阻患者,行胸廓出口减压联合开放或腔内重建。围手术期并发症26.4%,出院时症状缓解率100%,随访期间再狭窄需再干预30.2%,多见于同侧血液透析通路患者。
要点
- 胸廓出口减压联合开放或腔内重建对症状性中心静脉梗阻安全有效。
- 同侧血液透析通路患者再狭窄和再干预风险较高。
- 围手术期并发症以伤口和心脏并发症为主,需注意监测。
核心结论
- 在作者决策阈值下,开放和腔内手术对症状性胸廓出口综合征及动静脉通路相关锁骨下静脉疾病均具有较低并发症率和较高疗效。
- 同侧血液透析通路通畅患者再狭窄常见。
研究设计与样本
- 前瞻性收集数据库的回顾性查询,纳入2011年10月至2016年8月期间因高度症状性胸廓出口综合征或同侧动静脉通路相关中心静脉梗阻接受治疗的患者。
- 共53例患者接受54次手术,68%为男性,平均年龄50.1岁。
主要发现
- 手术指征包括传统胸廓出口综合征的静脉流出道梗阻(n=19)和同侧透析通路相关肋锁关节狭窄(n=34)。
- 8例因急性闭塞行术中药物机械溶栓;所有患者均行肋锁关节减压,48例行锁骨下第一肋切除,5例行锁骨切除术,6例附加胸锁旋转(Molina手术)。
- 18例(33%)行静脉外科重建:9例间置移植,1例颈静脉翻转,8例补片血管成形;36例(67%)行腔内手术:23例单纯静脉血管成形,13例均因透析通路相关狭窄行支架植入。
- 平均手术时间135(±63.5)分钟,平均估计失血量238(±261)mL,中位住院时间4天。
- 围手术期并发症14例(26.4%),包括伤口并发症(n=6)、心脏并发症(n=4)、再闭塞(n=3)、需胸腔引流管的血胸(n=1,发生于术中溶栓患者)。
临床怎么用
- 对于高度症状性胸廓出口综合征或动静脉通路相关中心静脉梗阻,可考虑胸廓出口减压联合开放或腔内重建以缓解症状。
- 术后需密切监测同侧血液透析通路患者的再狭窄,必要时及时再干预。
局限性
- 回顾性设计,样本量较小(53例),随访时间有限(平均13.6个月)。
- 单中心经验,决策阈值可能影响结果外推。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Subclavian vein stenosis or occlusion at the thoracic outlet is a problem associated with certain anatomic and environmental stresses (venous thoracic outlet syndrome [VTOS]), the presence of central venous catheters, and the high flows associated with arteriovenous (AV) access in the limb. We describe our experience with open and endovascular techniques for restoring patency in highly symptomatic patients. METHODS: A prospectively collected database of patients was queried for patients treated for central venous obstructive disease in the setting of highly symptomatic VTOS and ipsilateral AV access from October 2011 to August 2016. RESULTS: During the study period, 54 procedures were performed in 53 patients (68% male; mean age, 50.1 years). Indications for operation were venous outflow obstruction in patients with conventional VTOS (n = 19) or costoclavicular junction stenosis associated with ipsilateral dialysis access (n = 34). All patients had significant symptoms of swelling or pain. Eight patients underwent on-table pharmacomechanical thrombolysis for acute occlusion. All patients underwent costoclavicular junction decompression, 48 by infraclavicular first rib resection and 5 by claviculectomy; 6 patients underwent sternoclavicular rotation (Molina procedure) in addition to rib resection for further exposure. Surgical reconstruction of the vein was employed in 18 patients (33%); 9 underwent interposition grafting, 1 had jugular turndown, and 8 had patch angioplasty. The one patient undergoing two procedures suffered acute occlusion after patch repair followed by jugular turndown. Four patients underwent surgical reconstruction after thrombolysis. Endovascular procedures were performed in 36 patients (67%); 23 underwent venous angioplasty alone, and 13, all with hemodialysis access-associated stenosis, underwent stenting. Mean operative time was 135 (±63.5) minutes, and mean estimated blood loss was 238 (±261) mL. Median length of stay was 4 days. Perioperative complications were noted in 14 (26.4%) patients, including wound complications (n = 6), cardiac complications (n = 4), reocclusion (n = 3), and hemothorax requiring chest tube placement (n = 1) in a patient undergoing on-table thrombolysis. Mean follow-up was 13.6 (0.6-58.5) months. Initial clinical symptom relief was experienced in 100% of patients at the time of hospital discharge. During follow-up, 5 (9.4%) patients developed recurrent symptoms, 6 (11.3%) had reocclusion of the central system, and 16 (30.2%) required reintervention for restenosis, all but 2 in patients with ipsilateral hemodialysis access. Mean time to reintervention was 134 (±285) days. CONCLUSIONS: Given our decision-making threshold, both open and endovascular procedures are associated with relatively low morbidity and high efficacy for treatment of central venous occlusion in both symptomatic VTOS and AV access-associated subclavian vein disease. Restenosis is common in patients with a patent ipsilateral hemodialysis access.
引用
- Wooster M, Fernandez B, Summers KL, et al. Surgical and endovascular central venous reconstruction combined with thoracic outlet decompression in highly symptomatic patients. J Vasc Surg Venous Lymphat Disord. 2018. PMID: 30442583. doi:10.1016/j.jvsv.2018.07.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。